| Trial ID: | L7015 |
| Source ID: | NCT00665145
|
| Associated Drug: |
Sb-509
|
| Title: |
Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Diabetic Polyneuropathy
|
| Interventions: |
DRUG: SB-509|DRUG: SB-509|DRUG: Placebo|DRUG: SB-509
|
| Outcome Measures: |
Primary: Stem cells circulating in peripheral blood, One year | Secondary: Safety and Efficacy of SB-509, One year
|
| Sponsor/Collaborators: |
Sponsor: Sangamo Therapeutics
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
23
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-01
|
| Completion Date: |
2009-10
|
| Results First Posted: |
|
| Last Update Posted: |
2012-11-01
|
| Locations: |
La Jolla,, California, 92037, United States|Walnut Creek, California, 94598, United States|Houston, Texas, 77030, United States|San Antonio, Texas, 78229, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00665145
|
